{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:39:34Z","timestamp":1781606374867,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.omtm.2024.101251","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T15:41:08Z","timestamp":1713886868000},"page":"101251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rescue of myocytes and locomotion through AAV2\/9-2YF intracisternal gene therapy in a rat model of creatine transporter deficiency"],"prefix":"10.1016","volume":"32","author":[{"given":"Gabriella","family":"Fernandes-Pires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Duarte","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lanzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clothilde","family":"Roux-Petronelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alain","family":"Binz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cudalbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Sandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane","family":"Tenenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8068-3344","authenticated-orcid":false,"given":"Olivier","family":"Braissant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101251_bib1","doi-asserted-by":"crossref","first-page":"17760","DOI":"10.1074\/jbc.M208705200","article-title":"Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation","volume":"278","author":"Dolder","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2024.101251_bib2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00726-011-0877-3","article-title":"The creatine kinase system and pleiotropic effects of creatine","volume":"40","author":"Wallimann","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.omtm.2024.101251_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0005-2728(92)90096-K","article-title":"Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism","volume":"1102","author":"Wyss","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2024.101251_bib4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.omtm.2024.101251_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00726-011-0852-z","article-title":"Creatine deficiency syndromes and the importance of creatine synthesis in the brain","volume":"40","author":"Braissant","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.omtm.2024.101251_bib6","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00726-016-2189-0","article-title":"Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?","volume":"48","author":"Hanna-El-Daher","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.omtm.2024.101251_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1203\/00006450-199409000-00023","article-title":"Creatine deficiency in the brain: a new, treatable inborn error of metabolism","volume":"36","author":"St\u00f6ckler","year":"1994","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.omtm.2024.101251_bib8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/323765","article-title":"Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans","volume":"69","author":"Item","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2024.101251_bib9","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/320595","article-title":"X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome","volume":"68","author":"Salomons","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2024.101251_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1399-0004.2010.01460.x","article-title":"Clinical features and X-inactivation in females heterozygous for creatine transporter defect","volume":"79","author":"van de Kamp","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.omtm.2024.101251_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2013.10.018","article-title":"Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring","volume":"111","author":"St\u00f6ckler-Ipsiroglu","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101251_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.10455","article-title":"Lack of creatine in muscle and brain in an adult with GAMT deficiency","volume":"53","author":"Schulze","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2024.101251_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ab.2016.11.007","article-title":"Creatine in the central nervous system: From magnetic resonance spectroscopy to creatine deficiencies","volume":"529","author":"Rackayova","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.omtm.2024.101251_bib14","series-title":"Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases","first-page":"235","article-title":"Disorders of Creatine Metabolism","author":"St\u00f6ckler-Ipsiroglu","year":"2022"},{"key":"10.1016\/j.omtm.2024.101251_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jmedgenet-2013-101658","article-title":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","volume":"50","author":"van de Kamp","year":"2013","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtm.2024.101251_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10545-014-9713-8","article-title":"X-linked creatine transporter deficiency: clinical aspects and pathophysiology","volume":"37","author":"van de Kamp","year":"2014","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2024.101251_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pediatrneurol.2015.05.006","article-title":"Treatment of creatine transporter (SLC6A8) deficiency with oral S-adenosyl methionine as adjunct to L-arginine, glycine, and creatine supplements","volume":"53","author":"Jaggumantri","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.omtm.2024.101251_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1055\/s-0034-1386772","article-title":"Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders","volume":"34","author":"St\u00f6ckler-Ipsiroglu","year":"2014","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.omtm.2024.101251_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-011-9358-9","article-title":"Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect","volume":"35","author":"Valayannopoulos","year":"2012","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2024.101251_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-011-9345-1","article-title":"Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect","volume":"35","author":"van de Kamp","year":"2012","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2024.101251_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymgme.2021.12.005","article-title":"Current and potential new treatment strategies for creatine deficiency syndromes","volume":"135","author":"Fernandes-Pires","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101251_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/genes12081123","article-title":"The role of preclinical models in creatine transporter deficiency: Neurobiological mechanisms, biomarkers and therapeutic development","volume":"12","author":"Ghirardini","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.omtm.2024.101251_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11011-018-0197-3","article-title":"Treatment outcome of creatine transporter deficiency: international retrospective cohort study","volume":"33","author":"Bruun","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.omtm.2024.101251_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016187","article-title":"Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency","volume":"6","author":"Skelton","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101251_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.12688\/f1000research.5369.1","article-title":"A novel mouse model of creatine transporter deficiency","volume":"3","author":"Baroncelli","year":"2014","journal-title":"F1000Res."},{"key":"10.1016\/j.omtm.2024.101251_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fphys.2018.00773","article-title":"A mouse model of creatine transporter deficiency reveals impaired motor function and muscle energy metabolism","volume":"9","author":"Stockebrand","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtm.2024.101251_bib27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jimd.12137","article-title":"Deletion of the creatine transporter gene in neonatal, but not adult, mice leads to cognitive deficits","volume":"42","author":"Udobi","year":"2019","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2024.101251_bib28","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1093\/hmg\/ddw252","article-title":"A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging","volume":"25","author":"Baroncelli","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2024.101251_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41598-018-37303-1","article-title":"A nervous system-specific model of creatine transporter deficiency recapitulates the cognitive endophenotype of the disease: a longitudinal study","volume":"9","author":"Molinaro","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101251_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112254","article-title":"Creatine transporter knockout mice (Slc6a8) show increases in serotonin-related proteins and are resilient to learned helplessness","volume":"377","author":"Abdulla","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.omtm.2024.101251_bib31","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1172\/JCI59373","article-title":"Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency","volume":"122","author":"Kurosawa","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101251_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12461","article-title":"Cognitive deficits and increases in creatine precursors in a brain-specific knockout of the creatine transporter gene Slc6a8","volume":"17","author":"Udobi","year":"2018","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.omtm.2024.101251_bib33","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41598-020-80824-x","article-title":"A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism","volume":"11","author":"Duran-Trio","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101251_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jimd.12470","article-title":"Creatine transporter-deficient rat model shows motor dysfunction, cerebellar alterations, and muscle creatine deficiency without muscle atrophy","volume":"45","author":"Duran-Trio","year":"2022","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2024.101251_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.55","article-title":"AAV9-mediated central nervous system\u2013targeted gene delivery via cisterna magna route in mice","volume":"3","author":"Lukashchuk","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101251_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1089\/hum.2013.005","article-title":"Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates","volume":"24","author":"Samaranch","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101251_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cne.23667","article-title":"The distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity","volume":"523","author":"Lowe","year":"2015","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.omtm.2024.101251_bib38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101251_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101251_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(00)00269-2","article-title":"Endogenous synthesis and transport of creatine in the rat brain: an in\u00a0situ hybridization study","volume":"86","author":"Braissant","year":"2001","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.omtm.2024.101251_bib41","doi-asserted-by":"crossref","first-page":"7056","DOI":"10.1523\/JNEUROSCI.3924-14.2015","article-title":"Neuronal morphology generates high-frequency firing resonance","volume":"35","author":"Ostojic","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2024.101251_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.nbd.2009.10.022","article-title":"Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes","volume":"37","author":"Braissant","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2024.101251_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8135671","article-title":"The cerebellum posterior lobe associates with the exophthalmos of primary hyperthyroidism: A resting-state fMRI study","volume":"2019","author":"Liu","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.omtm.2024.101251_bib44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13861","article-title":"Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells","volume":"140","author":"Merkel","year":"2017","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.omtm.2024.101251_bib45","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10545-011-9433-2","article-title":"Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers","volume":"35","author":"Braissant","year":"2012","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2024.101251_bib46","article-title":"Skeletal muscle: A review of molecular structure and function","volume":"12","author":"Mukund","year":"2020","journal-title":"health and disease"},{"key":"10.1016\/j.omtm.2024.101251_bib47","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14791","article-title":"Cross-talk between motor neurons and myotubes via endogenously secreted neural and muscular growth factors","volume":"9","author":"Saini","year":"2021","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.omtm.2024.101251_bib48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s42003-023-05204-3","article-title":"Network of muscle fibers activation facilitates inter-muscular coordination, adapts to fatigue and reflects muscle function","volume":"6","author":"Garcia-Retortillo","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtm.2024.101251_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.610964","article-title":"The neuromuscular junction in health and disease: Molecular mechanisms governing synaptic formation and homeostasis","volume":"13","author":"Rodr\u00edguez Cruz","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtm.2024.101251_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146832","article-title":"Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies","volume":"1739","author":"Bailey","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.omtm.2024.101251_bib51","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101251_bib52","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101251_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/hum.2017.026","article-title":"Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101251_bib54","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/jvi.70.7.4646-4654.1996","article-title":"A \"humanized\" green fluorescent protein cDNA adapted for high-level expression in mammalian cells","volume":"70","author":"Zolotukhin","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101251_bib55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnmol.2014.00092","article-title":"Intracisternal delivery of NF\u03baB-inducible scAAV2\/9 reveals locoregional neuroinflammation induced by systemic kainic acid treatment","volume":"7","author":"Bockstael","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtm.2024.101251_bib56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/gt.2011.163","article-title":"Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9","volume":"19","author":"Dalkara","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101251_bib57","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1089\/hum.2019.249","article-title":"Rescue of adeno-associated virus production by shRNA cotransfection","volume":"31","author":"Guimaro","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101251_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/hgtb.2011.034","article-title":"Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences","volume":"23","author":"Aurnhammer","year":"2012","journal-title":"Hum. Gene Ther. Met."},{"key":"10.1016\/j.omtm.2024.101251_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00005072-199507000-00007","article-title":"Brain damage in neonatal meningitis caused by group B streptococci in rats","volume":"54","author":"Kim","year":"1995","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124000676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124000676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T11:04:38Z","timestamp":1726398278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124000676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2329050124000676"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101251","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rescue of myocytes and locomotion through AAV2\/9-2YF intracisternal gene therapy in a rat model of creatine transporter deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101251"}}